Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Stroke | 8 | 2022 | 309 | 3.310 |
Why?
|
| Myocardial Infarction | 8 | 2022 | 224 | 2.980 |
Why?
|
| Heart Failure | 6 | 2024 | 401 | 2.580 |
Why?
|
| Hydroxymethylglutaryl-CoA Reductase Inhibitors | 7 | 2025 | 165 | 1.710 |
Why?
|
| Medication Adherence | 5 | 2024 | 235 | 1.580 |
Why?
|
| Stroke Volume | 3 | 2024 | 104 | 1.570 |
Why?
|
| Hospitalization | 6 | 2024 | 804 | 1.450 |
Why?
|
| Cholesterol, LDL | 4 | 2025 | 112 | 1.430 |
Why?
|
| African Americans | 5 | 2020 | 439 | 1.280 |
Why?
|
| Proprotein Convertase 9 | 2 | 2019 | 2 | 1.200 |
Why?
|
| Cardiovascular Diseases | 3 | 2022 | 532 | 1.050 |
Why?
|
| Hypertension | 5 | 2024 | 469 | 1.030 |
Why?
|
| Male | 21 | 2025 | 9804 | 0.990 |
Why?
|
| Hypercholesterolemia | 1 | 2025 | 25 | 0.950 |
Why?
|
| Diabetes Mellitus, Type 1 | 2 | 2023 | 118 | 0.940 |
Why?
|
| Safety-net Providers | 1 | 2025 | 55 | 0.920 |
Why?
|
| Physicians, Primary Care | 1 | 2025 | 62 | 0.900 |
Why?
|
| Humans | 26 | 2025 | 17314 | 0.900 |
Why?
|
| Female | 21 | 2025 | 12396 | 0.890 |
Why?
|
| Middle Aged | 15 | 2025 | 7836 | 0.870 |
Why?
|
| Attitude of Health Personnel | 1 | 2025 | 197 | 0.850 |
Why?
|
| Natural Language Processing | 1 | 2024 | 60 | 0.840 |
Why?
|
| Patient Compliance | 1 | 2025 | 277 | 0.820 |
Why?
|
| Aged | 17 | 2024 | 6084 | 0.780 |
Why?
|
| United States | 13 | 2024 | 3866 | 0.720 |
Why?
|
| Politics | 1 | 2020 | 10 | 0.680 |
Why?
|
| Healthcare Disparities | 2 | 2020 | 202 | 0.660 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2023 | 664 | 0.650 |
Why?
|
| Loss of Function Mutation | 1 | 2019 | 3 | 0.640 |
Why?
|
| Lipoprotein(a) | 1 | 2019 | 5 | 0.640 |
Why?
|
| Incidence | 7 | 2023 | 1266 | 0.630 |
Why?
|
| Stress, Psychological | 1 | 2020 | 134 | 0.620 |
Why?
|
| Nutrition Surveys | 1 | 2019 | 56 | 0.600 |
Why?
|
| Perception | 1 | 2019 | 56 | 0.600 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2019 | 44 | 0.590 |
Why?
|
| Forecasting | 1 | 2019 | 68 | 0.590 |
Why?
|
| Self Report | 2 | 2017 | 257 | 0.580 |
Why?
|
| Adult | 10 | 2025 | 7500 | 0.570 |
Why?
|
| Cognition Disorders | 1 | 2017 | 30 | 0.550 |
Why?
|
| Genetic Variation | 1 | 2017 | 77 | 0.540 |
Why?
|
| Delivery of Health Care, Integrated | 2 | 2020 | 535 | 0.540 |
Why?
|
| Cognition | 1 | 2017 | 81 | 0.530 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 184 | 0.520 |
Why?
|
| Insurance Coverage | 1 | 2017 | 104 | 0.500 |
Why?
|
| Ethnic Groups | 1 | 2019 | 451 | 0.490 |
Why?
|
| Risk Factors | 8 | 2023 | 3258 | 0.480 |
Why?
|
| Aged, 80 and over | 7 | 2024 | 1925 | 0.480 |
Why?
|
| Angiotensin-Converting Enzyme Inhibitors | 3 | 2020 | 84 | 0.470 |
Why?
|
| Continental Population Groups | 1 | 2017 | 286 | 0.460 |
Why?
|
| Retrospective Studies | 8 | 2023 | 2415 | 0.440 |
Why?
|
| Ventricular Function, Left | 2 | 2024 | 53 | 0.400 |
Why?
|
| Age Factors | 4 | 2024 | 878 | 0.380 |
Why?
|
| Sex Factors | 3 | 2024 | 603 | 0.370 |
Why?
|
| Antihypertensive Agents | 2 | 2024 | 154 | 0.330 |
Why?
|
| Pandemics | 2 | 2023 | 287 | 0.330 |
Why?
|
| Angiotensin Receptor Antagonists | 2 | 2020 | 53 | 0.320 |
Why?
|
| Cohort Studies | 5 | 2023 | 2514 | 0.300 |
Why?
|
| Adolescent | 5 | 2023 | 3538 | 0.290 |
Why?
|
| Phenotype | 2 | 2019 | 149 | 0.290 |
Why?
|
| Prevalence | 3 | 2023 | 840 | 0.290 |
Why?
|
| Cross-Sectional Studies | 2 | 2025 | 1280 | 0.280 |
Why?
|
| Young Adult | 4 | 2023 | 2465 | 0.260 |
Why?
|
| California | 2 | 2024 | 2311 | 0.250 |
Why?
|
| Medicare | 3 | 2024 | 192 | 0.240 |
Why?
|
| Interviews as Topic | 1 | 2025 | 306 | 0.220 |
Why?
|
| Life Style | 1 | 2025 | 316 | 0.210 |
Why?
|
| Prospective Studies | 4 | 2023 | 1226 | 0.210 |
Why?
|
| Disease Progression | 1 | 2024 | 259 | 0.210 |
Why?
|
| Pre-Exposure Prophylaxis | 1 | 2023 | 18 | 0.210 |
Why?
|
| Diabetic Retinopathy | 1 | 2023 | 17 | 0.200 |
Why?
|
| Retinal Diseases | 1 | 2023 | 17 | 0.200 |
Why?
|
| Acute Disease | 1 | 2022 | 144 | 0.180 |
Why?
|
| Surveys and Questionnaires | 1 | 2025 | 1282 | 0.180 |
Why?
|
| Time Factors | 3 | 2020 | 1039 | 0.170 |
Why?
|
| Calcium Channel Blockers | 1 | 2020 | 15 | 0.170 |
Why?
|
| Proportional Hazards Models | 1 | 2022 | 701 | 0.160 |
Why?
|
| Prognosis | 2 | 2020 | 603 | 0.160 |
Why?
|
| Rosuvastatin Calcium | 1 | 2019 | 4 | 0.160 |
Why?
|
| Inpatients | 1 | 2020 | 79 | 0.160 |
Why?
|
| Aftercare | 1 | 2019 | 47 | 0.150 |
Why?
|
| Outpatients | 1 | 2020 | 101 | 0.150 |
Why?
|
| Health Status Disparities | 1 | 2020 | 149 | 0.150 |
Why?
|
| Drug Utilization | 1 | 2019 | 121 | 0.150 |
Why?
|
| Follow-Up Studies | 2 | 2019 | 1151 | 0.150 |
Why?
|
| Glomerular Filtration Rate | 1 | 2019 | 153 | 0.140 |
Why?
|
| Neuropsychological Tests | 1 | 2017 | 43 | 0.140 |
Why?
|
| Law Enforcement | 1 | 2017 | 2 | 0.130 |
Why?
|
| Accidents, Traffic | 1 | 2017 | 15 | 0.130 |
Why?
|
| HIV Infections | 1 | 2023 | 712 | 0.130 |
Why?
|
| Child | 1 | 2023 | 2403 | 0.130 |
Why?
|
| Biomarkers | 1 | 2017 | 307 | 0.130 |
Why?
|
| Drug Prescriptions | 1 | 2017 | 146 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 1 | 2017 | 372 | 0.120 |
Why?
|
| Comorbidity | 2 | 2020 | 560 | 0.070 |
Why?
|
| Reproducibility of Results | 2 | 2020 | 357 | 0.070 |
Why?
|
| Patient Discharge | 2 | 2019 | 153 | 0.060 |
Why?
|
| Risk Assessment | 2 | 2020 | 1076 | 0.060 |
Why?
|
| Fumarates | 1 | 2023 | 4 | 0.050 |
Why?
|
| Adenine | 1 | 2023 | 8 | 0.050 |
Why?
|
| Tenofovir | 1 | 2023 | 18 | 0.050 |
Why?
|
| Retreatment | 1 | 2020 | 2 | 0.040 |
Why?
|
| Geography | 1 | 2020 | 39 | 0.040 |
Why?
|
| Needs Assessment | 1 | 2019 | 65 | 0.040 |
Why?
|
| Confidence Intervals | 1 | 2019 | 231 | 0.040 |
Why?
|
| Longitudinal Studies | 1 | 2020 | 674 | 0.040 |
Why?
|
| Population Surveillance | 1 | 2020 | 252 | 0.040 |
Why?
|
| European Continental Ancestry Group | 1 | 2020 | 476 | 0.030 |
Why?
|
| Databases, Factual | 1 | 2019 | 304 | 0.030 |
Why?
|
| Severity of Illness Index | 1 | 2019 | 437 | 0.030 |
Why?
|
| Contrast Sensitivity | 1 | 2017 | 1 | 0.030 |
Why?
|
| Automobile Driving | 1 | 2017 | 10 | 0.030 |
Why?
|
| Alabama | 1 | 2017 | 23 | 0.030 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2017 | 120 | 0.030 |
Why?
|
| Independent Living | 1 | 2017 | 24 | 0.030 |
Why?
|
| Health Behavior | 1 | 2019 | 346 | 0.030 |
Why?
|
| Treatment Outcome | 1 | 2017 | 1160 | 0.030 |
Why?
|
Concepts
(116)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(14)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People who are also in this person's primary department.
Explore
_
-->